The HSBC share price has slumped and moved into a correction after falling by 12% from its highest point this year. It has ...

HSBC has identified its top pharmaceutical stock picks, highlighting companies with strong growth prospects and solid execution strategies across both growth and value categories. The investment ...

HSBC’s stock (NYSE: HSBC) has performed quite well this year, increasing by approximately 21% since the beginning of January. In comparison, its competitor JP Morgan (NYSE: JPM) is only up about 10% ...

HSBC analysts just slashed their recommendation on the world's most valuable pharmaceutical company, Eli Lilly, signaling a ...

A recent analyst note from HSBC has sent ripples through the market, challenging the prevailing optimism surrounding pharmaceutical giant Eli Lilly. The bank do ...

Complete HSBC Holdings PLC ADR stock information by Barron's. View real-time HSBC stock price and news, along with industry-best analysis.

The price trend for HSBC (HSBC) has been bearish lately and the stock has lost 5.5% over the past week. However, the formation of a hammer chart pattern in its last trading session indicates that the ...

HSBC Holdings Plc delivered a mixed Q3 2025, with resilient core operations but earnings impacted by litigation and legacy issues. HSBC's net interest income and fee growth were strong, especially in ...

GAMMA Investing LLC increased its holdings in shares of HSBC Holdings plc (NYSE:HSBC – Free Report) by 24.7% during the first quarter, according to the company in its most recent 13F filing with the ...

HSBC Holdings HSBC is undergoing a strategic transformation, shifting its focus toward Asia while restructuring key parts of its global operations. Let’s have a look at the bank’s strategic plan and ...